NYSEMKT: CANFCan Fite Biopharma Ltd Stock Ownership - Who owns Can Fite Biopharma?
Insider buying vs selling
Have Can Fite Biopharma Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when CANF insiders and whales buy or sell their stock.
CANF Shareholders
What type of owners hold Can Fite Biopharma Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Morgan Stanley | 0.00% | 33,007 | $77.24k | Institution |
| Rhumbline Advisers | 0.00% | 17,922 | $41.94k | Institution |
| Susquehanna International Group LLP | 0.00% | 12,047 | $28.19k | Institution |
| Fifth Third Bancorp | 0.00% | 3,000 | $7.02k | Institution |
| National Bank Of Canada | 0.00% | 600 | $1.40k | Institution |
| Citigroup Inc | 0.00% | 553 | $1.29k | Institution |
| Jpmorgan Chase Co | 0.00% | 460 | $1.08k | Institution |
| Td Waterhouse Canada Inc | 0.00% | 20 | $46.80 | Institution |
| Concourse Financial Group Securities Inc | 0.00% | 0 | $0.00 | Institution |
CANF vs Biotech Stocks
Can Fite Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.